Loading clinics…

CDC reporting unit 843

Fora Fertility, PLLC

715 W. 34th St, Austin, TX 78705 · address reported for 2022.

Own-egg outcomes

Live-birth deliveries per intended retrieval, all diagnoses, for retrievals started in 2021 and linked transfers within 12 months. Age is at retrieval start. Native fractions and protected/missing states are preserved.

Patient agePublished outcomeMatching intended retrievals
<3552.1%96
35-3723.9%67
38-4014.8%61
>404.8%21
Read these results

<35: About 52 in 100 retrieval attempts led to a live-birth delivery.

35-37: About 24 in 100 retrieval attempts led to a live-birth delivery.

38-40: About 15 in 100 retrieval attempts led to a live-birth delivery.

>40: About 5 in 100 retrieval attempts led to a live-birth delivery.

Treatment choices to discuss

<35 · Genetic testing was more common.

93.9% · National: 53.6%

Which test would you recommend for me, is it optional, and what does it cost?

Understanding embryo testing

Ask which test is proposed, why, and what it changes for you.

PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.

What the data show

CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.

ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.

Ask the clinic

  • Which test would you recommend for me?
  • Is it optional, and what are the alternatives?
  • What happens if no embryo is recommended for transfer?
  • Are biopsy and laboratory testing separate charges?

Source: ASRM PGT-A opinion.

35-37 · Genetic testing was more common.

97.2% · National: 63.8%

Which test would you recommend for me, is it optional, and what does it cost?

Understanding embryo testing

Ask which test is proposed, why, and what it changes for you.

PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.

What the data show

CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.

ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.

Ask the clinic

  • Which test would you recommend for me?
  • Is it optional, and what are the alternatives?
  • What happens if no embryo is recommended for transfer?
  • Are biopsy and laboratory testing separate charges?

Source: ASRM PGT-A opinion.

38-40 · Genetic testing was more common.

97.9% · National: 65.6%

Which test would you recommend for me, is it optional, and what does it cost?

Understanding embryo testing

Ask which test is proposed, why, and what it changes for you.

PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.

What the data show

CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.

ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.

Ask the clinic

  • Which test would you recommend for me?
  • Is it optional, and what are the alternatives?
  • What happens if no embryo is recommended for transfer?
  • Are biopsy and laboratory testing separate charges?

Source: ASRM PGT-A opinion.

>40 · Genetic testing was more common.

100.0% · National: 52.9%

Which test would you recommend for me, is it optional, and what does it cost?

Understanding embryo testing

Ask which test is proposed, why, and what it changes for you.

PGT includes tests for different purposes. PGT-A screens chromosome number; PGT-M tests for a particular inherited condition; PGT-SR addresses structural chromosome rearrangements.

What the data show

CDC reports PGT use broadly. These figures do not identify the test, establish a requirement, or show that testing caused better results.

ASRM has not established a benefit from routine PGT-A screening for every IVF patient. A higher success rate after transfer does not by itself establish a benefit per retrieval.

Ask the clinic

  • Which test would you recommend for me?
  • Is it optional, and what are the alternatives?
  • What happens if no embryo is recommended for transfer?
  • Are biopsy and laboratory testing separate charges?

Source: ASRM PGT-A opinion.

2022 transfers, all diagnoses and egg sources. Matching transfer counts are not published here. Reported use does not establish current policy or explain outcomes.

Donor treatment outcomes

Live-birth deliveries per transfer in 2022, all recipient ages and all diagnoses. Donated embryos remain a separate population.

Published transfer pathwayPublished outcomeMatching transfers
Fresh Embryos Fresh EggsNo matching cycles0
Fresh Embryos Frozen EggsNo matching cycles0
Frozen Embryos7 / 1717
Donated EmbryosNo matching cycles0

Combined donor-egg pathways: 7 / 17. Matching transfers: 17. This site weights the three donor-egg pathways by their matching transfer counts; a ~ marker identifies approximation from rounded published rates. Missing or protected active inputs prevent a combined rate.

Reported activity

Annual ART cycles are attempts, not unique patients. Unlinked and unavailable years remain gaps.

Report yearAnnual cycles
2013Not linked to this reporting unit
2014Not linked to this reporting unit
2015Not linked to this reporting unit
2016Not linked to this reporting unit
2017Not linked to this reporting unit
2018Not linked to this reporting unit
2019Not reported
2020200
2021526
2022709

Reported services

ServiceCDC value
Donor egg servicesNo
Donated embryo servicesNo
Embryo cryopreservation servicesYes
Egg cryopreservation servicesYes
Gestational carrier servicesYes

History and coverage, 2013–2022

Ten report years are checked individually. A missing or uncertain identity link stays a gap; it is not a zero or evidence of closure. A shared CDC reporting ID does not mean the same doctors or offices were included in every year. Calendar-year fresh-cycle measures and cumulative retrieval cohorts are different populations.

Report yearCoverageNative reporting nameExplanation
2013not linkedNo confirmed matchNo corroborated source reporting-unit match in this edition; not evidence of zero activity or nonexistence.
2014not linkedNo confirmed matchNo corroborated source reporting-unit match in this edition; not evidence of zero activity or nonexistence.
2015not linkedNo confirmed matchNo corroborated source reporting-unit match in this edition; not evidence of zero activity or nonexistence.
2016not linkedNo confirmed matchNo corroborated source reporting-unit match in this edition; not evidence of zero activity or nonexistence.
2017not linkedNo confirmed matchNo corroborated source reporting-unit match in this edition; not evidence of zero activity or nonexistence.
2018not linkedNo confirmed matchNo corroborated source reporting-unit match in this edition; not evidence of zero activity or nonexistence.
2019not linkedNo confirmed matchNo source data under this reporting ID; no predecessor substituted.
2020reportedFora Fertility, PLLCSame published CDC reporting ID; year-specific metadata retained.
2021reportedFora Fertility, PLLCSame published CDC reporting ID; year-specific metadata retained.
2022reportedFora Fertility, PLLCPublished 2022 reporting unit; source status: Open
2020 · native reported outcomes

Fora Fertility, PLLC · all diagnoses. Numeric outcome values are native percentages; fractions and protected strings remain as published.

Age or pathwayNative populationPublished valueValue state
<35Own eggs · intended retrievals started in 2019; linked transfers within 12 months0.0no cycles
35-37Own eggs · intended retrievals started in 2019; linked transfers within 12 months0.0no cycles
38-40Own eggs · intended retrievals started in 2019; linked transfers within 12 months0.0no cycles
>40Own eggs · intended retrievals started in 2019; linked transfers within 12 months0.0no cycles
Fresh Embryos Frozen EggsDonor / donated-embryo transfers in 20200.0no cycles
Frozen EmbryosDonor / donated-embryo transfers in 2020"*/5"suppressed
Fresh Embryos Fresh EggsDonor / donated-embryo transfers in 20200.0no cycles
Donated EmbryosDonor / donated-embryo transfers in 20200.0no cycles

CDC Success Rates · CDC Summary

2021 · native reported outcomes

Fora Fertility, PLLC · all diagnoses. Numeric outcome values are native percentages; fractions and protected strings remain as published.

Age or pathwayNative populationPublished valueValue state
<35Own eggs · intended retrievals started in 2020; linked transfers within 12 months35.3reported
35-37Own eggs · intended retrievals started in 2020; linked transfers within 12 months34.6reported
38-40Own eggs · intended retrievals started in 2020; linked transfers within 12 months"7/19"fraction
>40Own eggs · intended retrievals started in 2020; linked transfers within 12 months"*/8"suppressed
Frozen EmbryosDonor / donated-embryo transfers in 2021"*/13"suppressed
Donated EmbryosDonor / donated-embryo transfers in 20210.0no cycles
Fresh Embryos Fresh EggsDonor / donated-embryo transfers in 20210.0no cycles
Fresh Embryos Frozen EggsDonor / donated-embryo transfers in 20210.0no cycles

CDC Success Rates · CDC Summary

Current native observations (JSON) · 2013–2022 history and coverage (JSON) · Citation

Original sources and context

Every outcome above uses its original CDC population. Select an underlined figure in the interactive explorer for its native definition, footnote and source. The explorer also includes reviewed history, patient mix, national references and clinic-figure exports.